Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase NA 2Phase 2 2

Status

Unknown 2Terminated 1Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Classical hematology 2Tumor-Agnostic 1

Conditions

Venous Thromboembolism 4Neoplasms 4Venous Thrombosis 2Carcinoma, Non-Small-Cell Lung 2Stomach Neoplasms 1Small Cell Lung Carcinoma 1Malignant Female Reproductive System Neoplasm 1Abdominal Neoplasms 1

Interventions

Paclitaxel 20Gemcitabine 16Dexamethasone 16Bevacizumab 16Docetaxel 15Oxaliplatin 14Cyclophosphamide 13Carboplatin 12Capecitabine 12Sorafenib 11Fluorouracil 11Leucovorin 10Cisplatin 10pembrolizumab 9Pemetrexed 9Epoetin Alfa 9venetoclax 8Prednisone 8Fentanyl 8Drug Therapy 8Doxorubicin 8atezolizumab 7Rivaroxaban 7Rituximab 7Darbepoetin alfa 7Anastrozole 7Panitumumab 6Ondansetron 6Morphine 6Irinotecan 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Neoplasms × Enoxaparin × Clear all
NCT04999176 2021-08-10

VALERIA

Science Valley Research Institute

Phase 3 Unknown
440 enrolled
Classical hematology

Neoplasms, Venous Thromboembolism

NCT04462003 2020-07-08

DVT

Beni-Suef University

Phase 3 Unknown
100 enrolled

Neoplasms, Venous Thrombosis

NCT01164046 2014-12-03

Longheva

University Medical Center Groningen

Phase 3 Terminated
56 enrolled
Classical hematology

Neoplasms, Venous Thrombosis, Venous Thromboembolism

NCT00375076 2009-09-18

Comparison of Two Different Dosages of Low-molecular Weight Heparin in Cancer Patients

Medical University of Vienna

Phase 3 Completed
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡